NDC 63323-011

Chloramphenicol Sodium Succinate

Chloramphenicol Sodium Succinate

Chloramphenicol Sodium Succinate is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Chloramphenicol Sodium Succinate.

• Product ID: 63323-011_00bd45d9-faa9-442c-a66b-3d18c004cfcc
• NDC: 63323-011
• Product Type: Human Prescription Drug
• Proprietary Name: Chloramphenicol Sodium Succinate
• Generic Name: Chloramphenicol Sodium Succinate
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2001-01-12
• Marketing Category: ANDA / ANDA
• Application Number: ANDA062365
• Labeler Name: Fresenius Kabi USA, LLC
• Substance Name: CHLORAMPHENICOL SODIUM SUCCINATE
• Active Ingredient Strength: 1 g/10mL
• Pharm Classes: Amphenicol-class Antibacterial [EPC],Amphenicols [EXT]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 63323-011-15

10 VIAL in 1 TRAY (63323-011-15) > 10 mL in 1 VIAL

• Marketing Start Date: 2001-01-12
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63323-011-15 [63323001115]

Chloramphenicol Sodium Succinate INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA062365
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2001-01-12

Drug Details

Active Ingredients

Ingredient	Strength
CHLORAMPHENICOL SODIUM SUCCINATE	1 g/10mL

OpenFDA Data

• SPL SET ID: aed29594-211d-49ef-813f-131975a8d0e3
• Manufacturer:
  • Fresenius Kabi USA, LLC
• UNII:
  • 872109HX6B
• RxNorm Concept Unique ID - RxCUI:
  • 239200

Pharmacological Class

• Amphenicol-class Antibacterial [EPC]
• Amphenicols [EXT]